LENZ Financials
Lenz Therapeutics Inc - Financial statements & key metrics
Stock Price
$10.18
Market Cap
$319.19M
EPS
$-2.85
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
-
Gross Profit
-
Operating Income
-
Net Income
$-49.77M
EPS (Diluted)
$-2.34
Balance Sheet Highlights
Total Assets
$215.30M
Total Liabilities
$11.22M
Shareholders Equity
-
Cash & Equivalents
$20.16M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-59.39M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
97.8%
Operating Margin
-24.2%
ROE
-0.3%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is LENZ revenue?
View LENZ's income statement for detailed revenue data.
Is LENZ profitable?
LENZ reported a loss of $49.77M in the most recent quarter.
What is LENZ market cap?
LENZ has a market capitalization of $319.19M, making it a small-cap stock.
Does LENZ have debt?
View LENZ's balance sheet for debt information.
What is LENZ cash flow?
Cash flow data is available in the full financial statements.